SLU-PP-332 is an experimental compound, often referred to as an "exercise mimetic," that is being researched for its ability to replicate many of the metabolic benefits of physical activity by activating estrogen-related receptors (ERRs) in the body. Its potential benefits, primarily observed in preclinical animal studies, include:Metabolic and Weight Management Physical Performance and Longevity Potential Therapeutic Applications https://www.muscleandfitness.com/features/feature-news/a-new-drug-slu-pp-332-mimics-the-effects-of-exercise-in-the-body/https://www.jrenendo.com/PDF/jre-10-e25143.pdfhttps://www.peptidesciences.com/peptide-research/what-is-slu-pp-332-how-does-it-workhttps://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.9682https://www.medicalnewstoday.com/articles/new-drug-may-help-lose-weight-reduce-fat-by-mimicking-exercise